Whitepaper
20 Aug 2019

Interview with Dr K Anand Kumar, Managing director of Indian Immunologicals Limited

PDF 381 kB

An interview with Dr K Anand Kumar, Managing director, Indian Immunologicals Limited regarding the company's future growth plans & current R&D pipeline.

Content provided by our supplier

Indian Immunologicals Ltd

  • IN
  • 2019
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator

Other Content from Indian Immunologicals Ltd (2)

  • News COVID-19 VACCINE DEVELOPMENT

    Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

    Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.